250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science Startup Investors in France in December 2024

A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.

Top 50 Life Science Startup Investors in France in December 2024

Investor Life Science France investments
Bpifrance 10
Kurma Partners 7
Seventure Partners 5
Omnes Capital 5
Idinvest Partners 4
Paca Investissement 4
Karista 3
AdBio partners 3
Sofinnova Partners 3
Blue Horizon Corporation 3
Boehringer Ingelheim Venture Fund 3
Galia Gestion 3
Heartcore Capital 2
Kinled Holding 2
Beyond Impact 2
Thia Ventures 2
Advent Life Sciences 2
Partech 2
Sylvain Zimmer 2
Horizons Ventures 2
XAnge 2
Air Street Capital 2
Eutopia VC 2
Siparex Groupe 2
Sofimac Investment Managers 2
AQUITI Gestion 2
JDRF T1D Fund 2
Point Nine 2
WiSEED 2
IRDI SORIDEC Gestion 2
IXO Private Equity 1
Bioqube Ventures 1
Roche Venture Fund 1
Lundbeckfonden Ventures 1
Angels Santé 1
Shire 1
CIC Finance 1
Eurobail 1
Meusinvest (Noshaq) 1
Bertrand Jacquelot 1
Resiliance 1
Sofipaca 1
Earlybird Venture Capital 1
Thai Union Ventures 1
Eli Lilly 1
Sudinnova 1
Afone Participations 1
AxLR 1
CELESTE 1
Irwan Bello 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Bpifrance VC Fund · Maisons-alfort, Ile-de-France, France · 79 investments in the past 12 months
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France, United States, Switzerland
Portfolio highlights
  • Dfns — Supercharge your platform with keyless custody as a service. One API to generate secure wallets, manage your crypto, sign transactions, set up business rules, monitor security, and more.
  • Biolevate — Accelerating Therapeutic Innovation: AI-Enhanced Workflow Automation
  • Orakl Oncology — Cultivated with love by the Orakl team.
Kurma Partners VC Fund · Paris, Ile-de-France, France · 8 investments in the past 12 months
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Series A, Series B, Seed
  • France, Switzerland, Spain
Portfolio highlights
  • Omnidoc — Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.
  • Raidium — Radiology augmented GPT to tackle the complexity of precision medicine
  • PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
Seventure Partners VC Fund · Paris, Ile-de-France, France · 9 investments in the past 12 months
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series A, Series B, Funding Round
  • France, United States, Germany
Portfolio highlights
  • Otoqi — Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for the automotive professionals.
  • Siit — Siit is a modern IT service management platform. Conversational, integrated and AI-powered service desk for IT and internal operation teams. Simplify internal operations today!
  • Sequentia Biotech — Sequentia Biotech is a bioinformatics company that offers services for healthcare, pharma, agriculture, industry and environment.
Omnes Capital VC Fund · Paris, Ile-de-France, France · 6 investments in the past 12 months
Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Series A, Funding Round, Series B
  • France, Germany, United States
Portfolio highlights
  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • Carbyon — Carbyon is a Netherlands-based company that develops direct air capture (DAC) technologies. The company's fuels help to replace fossil hydrocarbons with electrical batteries or hydrogen (H2), alternative energy carriers that are used to store renewable electricity and make major changes to transportation facilities, energy grids, and gastransportation networks, filters CO2 from the air and supply it in a purified form to make kerosene for aircraft, enabling existing fossil industry to re-use and repurpose these storage and transport facilities for renewable hydrocarbons.
  • The Exploration Company — For Space & Non-Space Industries.
Idinvest Partners VC Fund · Paris, Ile-de-France, France
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Funding Round
  • France, United States, Spain
Portfolio highlights
  • Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability
Paca Investissement VC Fund · Paris, Ile-de-France, France
Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.
Show more
Investment focus
  • Software, Internet, Manufacturing
  • Seed, Funding Round, Series A
  • France
Portfolio highlights
  • GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.
Karista VC Fund · Paris, Ile-de-France, France · 7 investments in the past 12 months
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Seed, Series A, Series B
  • France, United States, Finland
Portfolio highlights
  • Deemea — Deemea is a collaborative AI platform that connects and provides services for the analysis of medical data for physicians. It uses its expertise in clinical research, data science, and software development to help healthcare professionals.
  • 10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
  • Brightflow — Brightflow operates as a medical device startup.
AdBio partners VC Fund · Paris, Ile-de-France, France
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Funding Round
  • France, Spain, Belgium
Portfolio highlights
  • Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 17 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • Genespire — Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
Blue Horizon Corporation VC Fund · Zürich, Zurich, Switzerland
Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.
Show more
Investment focus
  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Series A, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • WOW EARN — WOW EARN connects users to the blockchain, enabling them to mine, earn, and trade via decentralised mining, earning, and trading systems.
  • foodforecast — AI supported solution to reduce food waste.
  • New School Foods — Whole-muscle, plant-based seafood
Boehringer Ingelheim Venture Fund VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 2 investments in the past 12 months
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium
Portfolio highlights
  • Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
  • Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
  • Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
Galia Gestion VC Fund · Bordeaux, Aquitaine, France
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more
Investment focus
  • Software, Manufacturing, Biotechnology
  • Funding Round, Series A, Seed
  • France, United States
Portfolio highlights
  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Heartcore Capital VC Fund · Copenhagen, Hovedstaden, Denmark · 17 investments in the past 12 months
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more
Investment focus
  • Software, FinTech, Artificial Intelligence
  • Seed, Series A, Series B
  • Denmark, United States, Germany
Portfolio highlights
  • Luca — Luca's learning platform provides learning programs for primary and secondary school students. The learning platform offers pre-recorded K12 videos, gamified content and AI powered personalized study paths, covering the entire official academic curriculum and national exams prep. Luca is a VC backed startup with HQ in Madrid & MexicoCity
  • Rhinestone — Infrastructure for modular account abstraction
  • Barter — Barter enables decentralized applications by ensuring efficient transaction routing and optimization.
Kinled Holding VC Fund · New York, New York, United States
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more
Investment focus
  • Biotechnology, Health Care, Financial Services
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Switzerland
Portfolio highlights
  • Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
  • OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
  • Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.
Beyond Impact VC Fund · Minneapolis, Minnesota, United States
Beyond Impact is your trusted Managed Service Provider (MSP), delivering tailored IT solutions like managed IT services, cybersecurity, cloud computing, IT help desk support, and data backup. Our expert team aligns your IT with business goals, providing proactive monitoring and network security. Contact us today to streamline your IT operations for a secure, agile, and future-ready business. Beyond Impact: Empowering your IT success.
Show more
Investment focus
  • Food and Beverage, News, Seafood
  • Seed, Series A, Pre-Seed
  • France, Canada, Singapore
Portfolio highlights
  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Nowadays — The Nowadays nugget is made with just 7 simple, plant-based ingredients.
  • SEAFOOD REBOOT — Seafood Reboot's ambition is to promote worldwide best-in-class Fish substitutes from micro-algae for natural, healthy, sustainable food and to preserve marine wildlife.
Thia Ventures VC Fund · Genève, Geneve, Switzerland · 3 investments in the past 12 months
WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team
Show more
Investment focus
  • Biotechnology, Food and Beverage, Health Care
  • Series A, Seed, Series B
  • United States, France, Denmark
Portfolio highlights
  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • Protealis — Sustainable plant proteins for Europe​
  • Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Advent Life Sciences VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • United States, United Kingdom, France
Portfolio highlights
  • Argá Medtech — Novel Sine Wave Technology Promises Significant Advantages Over Existing Pulsed Field Cardiac Ablation Systems
  • PIC Therapeutics — PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
  • Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.
Partech VC Fund · Paris, Ile-de-France, France · 21 investments in the past 12 months
Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.
Show more
Investment focus
  • Software, E-Commerce, SaaS
  • Series A, Seed, Series B
  • United States, France, Germany
Portfolio highlights
  • KoRo — KoRo is a fast-growing FoodTech startup - one of the leading brands for healthy, long-lasting and sustainable food.
  • QPLIX Wealth Management Software — QPLIX lets Family Offices, IFAs and Asset Managers consolidate all asset data and streamline controlling, reporting and accounting.
  • Socium — Socium Job these are companies that recruit and offer real career opportunities to all those who share their values ​​and wish to invest in their development.
Sylvain Zimmer Angel · Paris, Ile-de-France, France
Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.
Show more
Investment focus
  • Software, Financial Services, SaaS
  • Seed, Pre-Seed, Angel
  • France, United States, United Kingdom
Portfolio highlights
  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Horizons Ventures VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 13 investments in the past 12 months
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
  • Medal — Gamers live here. Medal is the best way to record, clip, edit, and share your gaming clips and videos. Clip, Edit, Share, and Relive your gaming moments.
  • ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
XAnge VC Fund · Paris, Ile-de-France, France · 7 investments in the past 12 months
For 20 years, XAnge has been a key venture capital fund in Europe. With 70 startups in its portfolio, XAnge invests early in innovative tech companies.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Series A, Seed, Series B
  • France, Germany, Belgium
Portfolio highlights
  • TEEPTRAK — Teeptrak solutions are the results of several years of consulting in operations and strategy. One major learning is that there is a real need of simple tools to better understand industrial performance in order to improve it. They believe the IoT technologies combined with the good old Lean philosophy are the key to success.
  • Gladia.io — 1 stop shop AI API hub for developers
  • SamanTree Medical — SamanTree Medical has developed the Histolog Scanner, a confocal microscopy device intended for imaging the surface of excised human tissue specimens to visualize morphological microstructures. Easy-to-read images are available immediately, providing decision-making support at the point of care.
Air Street Capital VC Fund · London, England, United Kingdom · 5 investments in the past 12 months
Air Street Capital invests in AI-first companies.
Show more
Investment focus
  • Artificial Intelligence, Machine Learning, Biotechnology
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • intenseye — Intenseye | Reduce workplace incidents and increase efficiency with the world's #1 safety management software.
  • Profluent Bio — We are fluent in the language of protein design.
  • Interloom Technologies — Interloom offers AI-driven process automation for enterprises to maximize organizational efficiency and accuracy.
Eutopia VC VC Fund · Paris, Ile-de-France, France
Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups
Show more
Investment focus
  • Retail, E-Commerce, Food and Beverage
  • Seed, Series A, Funding Round
  • France, Belgium, Denmark
Portfolio highlights
  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
  • Nous anti-gaspi — We anti-Gapsi is the network of anti-waste food stores. This grocery store project offers producers and manufacturers the opportunity to their downgraded and unsold products at a fair price. They are a qualitative environment, they market products excluded from the usual mass distribution circuits for small defects, physical defects, contract-datenot respected, and end of series. They offer consumers a new mode of consumption that gives priority to common sense and that is at the same time smart, qualitative, and eco-responsible. In their stores, they offer you to find, in a warm atmosphere, a complete choice of food products to save waste: fruits and vegetables, fresh and frozen products, groceries, and even a small bulk section.
Siparex Groupe VC Fund · Paris, Ile-de-France, France
Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.
Show more
Investment focus
  • Manufacturing, Software, Information Technology
  • Private Equity, Funding Round, Seed
  • France, United States, Italy
Portfolio highlights
  • E-Recycle — E-Recycle is an online and offline store that specializes in recycling used high-tech products such as mobile phones, tablets, and PCs.
  • NeoPhotonics — NeoPhotonics design and manufacture advanced hybrid photonic integrated optoelectronic devices for ultra-fast communications networks, including optical components
  • Monet Associes — Monet + Associes is a public relations agency.
Sofimac Investment Managers VC Fund · Clermont-ferrand, Auvergne, France
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more
Investment focus
  • Biotechnology, Health Care, Manufacturing
  • Funding Round, Seed, Series A
  • France, Italy, Austria
Portfolio highlights
  • Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
AQUITI Gestion VC Fund · Bordeaux, Aquitaine, France · 3 investments in the past 12 months
Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Series A, Seed
  • France, United States
Portfolio highlights
  • Dionymer — dionymer creates endless opportunities for a multitude of industries. Replacing petrochemical polymers with a circular and biodegradable alternative.
  • Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.
  • ALOGIA Groupe — ALOGIA Groupe offers preventive health responses to senior people at home through care management and innovative services.
JDRF T1D Fund VC Fund · Boston, Massachusetts, United States · 3 investments in the past 12 months
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Funding Round, Series B
  • United States, France, Italy
Portfolio highlights
  • vTv Therapeutics — vTv Therapeutics, a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. Its mission is to utilize its innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.vTv Therapeutics has a pipeline of small molecule clinicaland pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation, and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv's product candidate pipeline, platform technology, scientific team, and strategic collaborations have enabled it to become a fully integrated pharmaceutical company.The company's commitment to drug discovery is reflected in its medical solutions and the many exciting potential new treatment options in its pipeline. The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.vTv Therapeutics is advancing several proprietary drug candidates. The company's lead candidate, azeliragon (aka TTP488), is a novel, orally bioavailable small molecule compound that is being developed for the treatment of Alzheimer's disease. In Phase 2 clinical trial in patients with mild to moderate Alzheimer's disease, azeliragon showed a statistically significant difference of more than 3 points in ADAS-cog at 18 months compared to placebo.Azeliragon has been granted Fast Track Designation and agreement on its Phase 3 protocol has been reached with FDA via a Special Protocol Assessment (SPA). The Phase 3 study in patients with mild Alzheimer's disease was initiated in April 2015 with a clear path forward to registration with the aim to demonstrate disease modification.vTv Therapeutics is also prosecuting the clinical development of TTP399, a novel functionally liver-selective Glucokinase Activator ("GKA") for the treatment of type 2 diabetes. In a Phase 2a study, TTP399 normalized patients' HbA1c without inducing hypoglycemia, after only six weeks of treatment. A six-month Phase 2 study is ongoing.
  • Eledon Pharmaceuticals — Eledon Pharmaceuticals, Inc. is a clinical-stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
  • Cour Pharmaceuticals Development — COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance...
Point Nine VC Fund · Berlin, Berlin, Germany · 6 investments in the past 12 months
Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.
Show more
Investment focus
  • Software, SaaS, Internet
  • Seed, Series A, Series B
  • Germany, United States, France
Portfolio highlights
  • Attio — Unlock your team's true potential with Attio, the data-driven CRM for modern teams. Manage everything from sales leads through to recruitment pipelines.
  • Hula Earth — Biodiversity Monitoring for Nature, Agriculture, and Infrastructure
  • Tengo — Tengo is a SaaS platform that helps businesses win more public tenders and design to simplify and centralize the entire tendering process.
WiSEED VC Fund · Toulouse, Midi-Pyrenees, France · 2 investments in the past 12 months
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more
Investment focus
  • Software, Manufacturing, Biotechnology
  • Seed, Funding Round, Equity Crowdfunding
  • France
Portfolio highlights
  • Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
  • Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
  • BiPER Therapeutics — BiPER Therapeutics : First-In-Class Therapeutics to Treat Cancer. Biotech company founded in 2021 to develop and commercialize novel therapeutics.
IRDI SORIDEC Gestion VC Fund · Toulouse, Midi-Pyrenees, France · 10 investments in the past 12 months
IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • France, Brazil, Singapore
Portfolio highlights
  • IsyBuy — IsyBuy is a smartphone application that allows to find restaurants and bars that have your way, consult the menu, place order, and still pay your bill directly from your cell phone, with just one click. It's the fastest, easiest, and safest way to borrow and pay. They will never have to wait to be served by a waiter, let alone beg to receivethe account or the card machine.
  • Keysom — Keysom is a French startup expert in the architecture of processor cores based on the RISC-V ISA. Keysom offers ad EDA tool to automatically build unique custom processors from the application code.
  • Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.
IXO Private Equity VC Fund · Toulouse, Midi-Pyrenees, France · 7 investments in the past 12 months
The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.
Show more
Investment focus
  • Health Care, Manufacturing, Biotechnology
  • Private Equity, Funding Round, Series A
  • France, United States, Canada
Portfolio highlights
  • F-Reg — F-Reg autonomous and intelligent hydraulic valves are designed to regulate and control flow patterns in sanitation networks. F-Reg sells solutions for regulating flow in networks (rainwater or wastewater) that rely on a patented valve that smooths out peaks in wet weather. The F-Reg device is self-contained and does not require power.
  • Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
  • Farmitoo — Farmitoo is an online purchase of farm equipment directly from manufacturers.
Bioqube Ventures VC Fund · Hasselt, Limburg, Belgium
A life science venture capital fund - investing globally in exciting science to accelerate breakthrough therapies in patients.
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Series A, Seed, Series B
  • United States, France, Ireland
Portfolio highlights
  • Enhanc3D Genomics — Enhanc3D Genomics is a spinout company from Babraham Institute.
  • SynOx Therapeutics — SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland.
  • Bicara Therapeutics — At Bicara, we are attacking cancer head-on by combining the precision of targeted therapies with the power of tumor-microenvironment modulators to create better medicines for patients.
Roche Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent ofcollaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, United Kingdom, Spain
Portfolio highlights
  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team Latest News See more Our Work OUR APPROACH ABOUT DIABETES
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Lundbeckfonden Ventures VC Fund · Copenhagen, Hovedstaden, Denmark
Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, United Kingdom, France
Portfolio highlights
  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • LEXEO Therapeutics — LEXEO Therapeutics is a fully integrated biotechnology company. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine. Beyond LEXEO Therapeutics’ lead programs – which are focused on both rare and non-rare monogenic (singlegenemutation) diseases – the company’s preclinical pipeline spans monogenic diseases, as well as hereditary and acquired diseases across a spectrum of patient population sizes and a range of unmet medical needs. Importantly, LEXEO Therapeutics will focus on advancing clinical programs through to commercialization, with the goal of maintaining an ongoing research collaboration with Weill Cornell Medicine’s Department of Genetic Medicine to help advance the company’s pre-clinical pipeline.
Angels Santé VC Fund · Puteaux, Ile-de-France, France · 4 investments in the past 12 months
Angels Santé is a networking site for investors and companies in the health sector.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Seed, Funding Round, Angel
  • France, India, United States
Portfolio highlights
  • Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
  • Odimma — Empowering personalized immunotherapy to treat cancer
  • SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Shire VC Fund · Dublin, Dublin, Ireland
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Show more
Investment focus
  • Biotechnology, Therapeutics, Biopharma
  • Series C, Series B, Series A
  • United States, France, Belgium
Portfolio highlights
  • Naurex — Naurex Inc. is a clinical-stage company developing novel therapies for depression and other CNS disorders based on a new mechanism of action for modulating the N-methyl-D-aspartic acid receptor (NMDAR). Using these discoveries, Naurex researchers have generated novel chemical drug classes known as glycine-site functional partial agonists (GFPAs),which modulate the receptor in a different way than existing NMDAR agents. The company's drug development programs based on its GFPA NMDAR modulators include the first-generation molecule, GLYX-13, the second-generation NRX-1050 small molecule series and additional compounds from Naurex's platform of novel NMDAR modulators.
  • Rani Therapeutics — Rani is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes. We have developed the RaniPill capsule, which is our novel, proprietary and patented platform technology, intended to replacesubcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. To date, we have successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using the RaniPill capsule. Our development efforts have enabled us to construct an extensive intellectual property portfolio that we believe provides us a competitive advantage.
  • Promethera Biosciences — Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology.Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way usingallogenic progenitor cells from healthy human livers.Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):
CIC Finance VC Fund · Austin, Texas, United States
CIC Finance is a firm that focuses on provided loan opportunities to individuals and businesses.
Show more
Investment focus
  • Health Care, Life Science, Therapeutics
  • Funding Round
  • France
Portfolio highlights
  • Polyplus-transfection — Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services.
Eurobail VC Fund · Paris, Ile-de-France, France
Eurobail is a specialized training company that works in the real estate, banking, and insurance industries.
Show more
Investment focus
  • Health Care, Life Science, Clinical Trials
  • Series A
  • France
Portfolio highlights
  • DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.
Meusinvest (Noshaq) VC Fund · Liège, Liege, Belgium · 8 investments in the past 12 months
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Funding Round
  • Belgium, France, Germany
Portfolio highlights
  • Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
  • Get Your Way — Discover the future of assisted reality with Get Your Way's aRdent smart glasses. Perfect for SMEs looking for innovative solutions to improve their business
  • Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
Bertrand Jacquelot Angel · Paris, Ile-de-France, France
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more
Investment focus
  • E-Commerce, Information Technology, Food and Beverage
  • Pre-Seed, Seed, Angel
  • France, United States
Portfolio highlights
  • Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
  • Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
  • Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Resiliance VC Fund · Bismarck, North Dakota, United States
Resilience Consulting offers talent, innovation, marketing, and performance improvement services to small and medium-sized businesses, they assist businesses in boosting growth, cutting expenses, and increasing engagement.
Show more
Investment focus
  • Life Science, Biotechnology, Waste Management
  • Seed
  • France
Portfolio highlights
  • Dionymer — Dionymer is putting money into the circular economy by creating a method that uses microorganisms to convert industrial organic waste into biodegradable polyhydroxyalkanoates, or PHA, polymers.
Sofipaca VC Fund · Aix-en-provence, Provence-Alpes-Cote d'Azur, France
Sofipaca supports SMEs and mid-caps in the SOUTH region in the long term in their development capital and transmission capital operations. The company was founded in 1984 and based in Aix en Provence, France.
Show more
Investment focus
  • Food and Beverage, Pharmaceutical, Manufacturing
  • Private Equity, Series A, Series B
  • France
Portfolio highlights
  • HalioDx — Veracyte translates the tumor immune response into clear insights to guide treatment decisions, inform biomarker development, or advance therapeutics.
  • Cintoo — Cintoo is essential for BIM to bridge the gap between your physical and virtual worlds.
  • Keep Cool — Keep Cool is a operator of a chain of fitness centers.
Earlybird Venture Capital VC Fund · Berlin, Berlin, Germany · 34 investments in the past 12 months
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Series A, Seed, Series B
  • Germany, United States, United Kingdom
Portfolio highlights
  • Mona AI — MONA AI is an automation software designed for the human resources services sector, aimed at streamlining HR processes and improving efficiency through artificial intelligence-driven solutions
  • Aleph Alpha — Aleph Alpha develops AI systems for modern security challenges.
  • Briefcase — Briefcase is an AI-powered tool for bookkeeping and month-end automation designed specifically for professional services practices.
Thai Union Ventures VC Fund · Samut Sakhon, Samut Sakhon, Thailand
Thai Union Ventures is a corporate venture arm of thai union group.
Show more
Investment focus
  • Life Science, Biotechnology, Food Processing
  • Series A
  • France
Portfolio highlights
  • Algama — Algama harvests the potential of algae to create food that's good for both people and the planet.
Eli Lilly VC Fund · Indianapolis, Indiana, United States · 11 investments in the past 12 months
Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It alsoconducts research to find products to treat diseases in animals and to increase the efficiency of animal food production. Products Neurosciences products, include Zyprexa, for the treatment of schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; Cymbalta, for the treatment of the major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, and in the United States for the management of fibromyalgia; Strattera, for the treatment of attention-deficit hyperactivity disorder in children, adolescents, and adults; Prozac, for the treatment of the major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and Symbyax, for the treatment of bipolar depression. Endocrinology products, include Humalog, Humalog Mix 75/25, and Humalog Mix 50/50tm, for the treatment of diabetes; Humulin, for the treatment of diabetes; Byetta, for the treatment of type 2 diabetes; Actos, for the treatment of type 2 diabetes; Evista, for the prevention and treatment of osteoporosis in postmenopausal women and for the reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer; Forteo, for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture; and Humatrope, for the treatment of human growth hormone deficiency and idiopathic short stature.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Series B, Funding Round
  • United States, United Kingdom, China
Portfolio highlights
  • OrsoBio — Developing first-in-class therapies to treat patients with metabolic disorders including diabetes, severe dyslipidemias, and more.
  • UpDoc — UpDoc is a technology-enabled services firm that offers the world's first unique conversational AI platform for autonomous prescription management.
  • Firefly Bio — Firefly specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
Sudinnova VC Fund · Lyon, Rhone-Alpes, France
Sudinnova is a venture capital firm that invests in information technology, electronics, life sciences, and clean technology sectors.
Show more
Investment focus
  • Software, Biotechnology, Medical
  • Funding Round, Series A, Seed
  • France
Portfolio highlights
  • Kerlink — Founded in 2004, Kerlink is a fast-growing, global and publicly traded provider of Internet of Things (IoT) infrastructure, software and services serving telecom operators, public authorities and businesses of all sizes to design, launch and operate IoT networks.Anticipating a booming market for communication solutions dedicated to connecteddevices, Kerlink founders – William Gouesbet, chairman and CEO, and Yannick Delibie, deputy CEO and CTIO – foresaw the role that RF communication technologies and their associated support platforms could play in M2M vertical segments like fleet management, metering and freight.A co-founder and board member of the LoRa Alliance, Kerlink specialises in end-to-end IoT network solutions for LoRaWAN cost-effective, energy-efficient and long-distance connectivity. The company designed the world’s first commercially available product range of outdoor carrier-grade for IoT dedicated networks.Kerlink also has continuously launched a range of embedded & ruggedized devices and applications for transportation using cellular connectivity, in addition to fleet management and tracking solutions, such as passenger information and entertainment, fuel-efficiency monitoring and car/bike sharing.
  • Lucibel — Lucibel is an innovative French group that designs and manufactures new-generation lighting products and solutions in France based on LED technology. LED technology is cost efficient, sustainable and smart. It is transforming the world and is now part of the digital era. Not only are Lucibel lighting solutions compatible with remote managementsystems. Light can now interact with its surroundings and be controlled and measured in real time. But it also allows for a new medium for data transmission, interactions and well-being thanks to the development by Lucibel of innovative and smart solutions.
  • Universign — Have your PDF documents signed online with Universign: the electronic signature and timestamping service recognised by Adobe Reader.
Afone Participations VC Fund · Paris, Ile-de-France, France
Afone Participations is a telecommunications and electronic payments company.
Show more
Investment focus
  • Software, Compliance, Life Science
  • Series A
  • France
Portfolio highlights
  • BMI System — BMI System is a management software editor for the pharmaceutical, medical, and cosmetics industries The company exports its software packages to Europe and America. With the NAYA Compliance application it has established itself as the leading French company for regulatory compliance software for the pharmaceutical industry.
AxLR VC Fund · Montpellier, Languedoc-Roussillon, France
AxLR specializes in the assistance of commercialization and academic research maturity-based innovative projects.
Show more
Investment focus
  • Life Science, Biotechnology
  • Pre-Seed
  • France
Portfolio highlights
  • Ingraalys — Ingraalys studies genomic and cellular plasticity during development and aging. Exploring the limitations of this plasticity prompted her to investigate the potential reversibility of cellular aging.
CELESTE VC Fund · Champs-sur-marne, Ile-de-France, France
CELESTE operates as an Internet provider for different companies. The company offers a range of solutions which covers Internet access, MPLS interconnection and fiber optics, IP telephony or ecological data center hosting. CELESTE was founded in 2001 and is headquartered in Champs-sur-marne, Ile-de-France.
Show more
Investment focus
Portfolio highlights
  • DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.
Irwan Bello Angel · San Francisco, California, United States · 3 investments in the past 12 months
Irwan Bello is an individual investor.
Show more
Investment focus
  • Information Technology, Internet, Life Science
  • Seed, Pre-Seed
  • France, United States
Portfolio highlights
  • Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
  • Lutra AI — Lutra AI is to simplify complex tasks that specializes in workflows, created by the platform.
  • Twin — Twin Labs, offer an automated tool for repetitive operations, such as onboarding new staff to all internal systems.
Investors by industry
Investors by country
Investors in France by industry